↓ Skip to main content

Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology

Overview of attention for article published in Frontiers in oncology, January 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology
Published in
Frontiers in oncology, January 2023
DOI 10.3389/fonc.2023.1083297
Pubmed ID
Authors

Filippo Merloni, Michela Palleschi, Caterina Gianni, Chiara Casadei, Annalisa Curcio, Antonino Romeo, Maddalena Rocchi, Simona Cima, Marianna Sirico, Samanta Sarti, Lorenzo Cecconetto, Marita Mariotti, Giandomenico Di Menna, Ugo De Giorgi

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 22%
Student > Ph. D. Student 1 11%
Student > Doctoral Student 1 11%
Student > Postgraduate 1 11%
Unknown 4 44%
Readers by discipline Count As %
Medicine and Dentistry 4 44%
Pharmacology, Toxicology and Pharmaceutical Science 1 11%
Unknown 4 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 February 2023.
All research outputs
#16,067,611
of 26,181,776 outputs
Outputs from Frontiers in oncology
#5,071
of 22,924 outputs
Outputs of similar age
#224,334
of 485,137 outputs
Outputs of similar age from Frontiers in oncology
#265
of 1,389 outputs
Altmetric has tracked 26,181,776 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,924 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 485,137 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 1,389 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.